Cargando…

The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study

End-of-life advance care planning (ACP) has become increasingly important in home care setting. In facilitating ACP discussion in home care setting, accurate understanding of patients’ survival would be beneficial because it would facilitate healthcare professionals to individualize ACP discussion....

Descripción completa

Detalles Bibliográficos
Autores principales: Kosaka, Makoto, Miyatake, Hirotomo, Kotera, Yasuhiro, Masunaga, Hidehisa, Arita, Satoshi, Tsunetoshi, Chie, Nishikawa, Yoshitaka, Ozaki, Akihiko, Beniya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545356/
https://www.ncbi.nlm.nih.gov/pubmed/34559116
http://dx.doi.org/10.1097/MD.0000000000027225
_version_ 1785114654271340544
author Kosaka, Makoto
Miyatake, Hirotomo
Kotera, Yasuhiro
Masunaga, Hidehisa
Arita, Satoshi
Tsunetoshi, Chie
Nishikawa, Yoshitaka
Ozaki, Akihiko
Beniya, Hiroyuki
author_facet Kosaka, Makoto
Miyatake, Hirotomo
Kotera, Yasuhiro
Masunaga, Hidehisa
Arita, Satoshi
Tsunetoshi, Chie
Nishikawa, Yoshitaka
Ozaki, Akihiko
Beniya, Hiroyuki
author_sort Kosaka, Makoto
collection PubMed
description End-of-life advance care planning (ACP) has become increasingly important in home care setting. In facilitating ACP discussion in home care setting, accurate understanding of patients’ survival would be beneficial because it would facilitate healthcare professionals to individualize ACP discussion. However, little is known about survival outcome of home care patients. This study aimed to clarify the outcome of patients and identify factors to better predict the survival outcome of home care patients with the focus on patients’ primary diseases. We conducted a retrospective analysis using data from 277 patients managed at a home care clinic in Japan and first treated in 2017 or 2018. Data regarding sociodemographic and clinical characteristics, and clinical outcome on December 31, 2019 were extracted. Using Kaplan–Meier product-limit method, we estimated the overall 30 days, 90 days, 1 year, and 3 year survival probabilities among the entire patients and their differences according to their primary disease. We also evaluated whether outcomes differed based on the primary disease or other factors using the hazard ratio and Cox proportional hazards regression. The overall survival probability was 82.5% at 30 days, 67.8% at 90 days, 52.7% at 1 year, and 39.1% at 3 years. The survival rates at 30 days, 90 days, 1 year, and 3 years were 64.6%, 33.4%, 9.5%, and 4.1% among cancer patients; 91.9%, 86.4%, 78.1%, and 47.0% among dementia patients; and 91.9%, 86.4%, 78.1%, and 47.0% among patients with other nervous and cerebrovascular diseases, respectively. Cox proportional hazard regression clarified that cancer patients (hazard ratio 6.53 [95% CI 4.16–10.28]) and older adults (hazard ratio 1.01 [95% CI 1.00–1.02]) were significantly more likely to die than dementia patients and young patients, respectively. Primary disease had a significant influence on the prediction of survival time and could be a useful indicator to individualize ACP in home care setting.
format Online
Article
Text
id pubmed-10545356
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105453562023-10-03 The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study Kosaka, Makoto Miyatake, Hirotomo Kotera, Yasuhiro Masunaga, Hidehisa Arita, Satoshi Tsunetoshi, Chie Nishikawa, Yoshitaka Ozaki, Akihiko Beniya, Hiroyuki Medicine (Baltimore) 6100 End-of-life advance care planning (ACP) has become increasingly important in home care setting. In facilitating ACP discussion in home care setting, accurate understanding of patients’ survival would be beneficial because it would facilitate healthcare professionals to individualize ACP discussion. However, little is known about survival outcome of home care patients. This study aimed to clarify the outcome of patients and identify factors to better predict the survival outcome of home care patients with the focus on patients’ primary diseases. We conducted a retrospective analysis using data from 277 patients managed at a home care clinic in Japan and first treated in 2017 or 2018. Data regarding sociodemographic and clinical characteristics, and clinical outcome on December 31, 2019 were extracted. Using Kaplan–Meier product-limit method, we estimated the overall 30 days, 90 days, 1 year, and 3 year survival probabilities among the entire patients and their differences according to their primary disease. We also evaluated whether outcomes differed based on the primary disease or other factors using the hazard ratio and Cox proportional hazards regression. The overall survival probability was 82.5% at 30 days, 67.8% at 90 days, 52.7% at 1 year, and 39.1% at 3 years. The survival rates at 30 days, 90 days, 1 year, and 3 years were 64.6%, 33.4%, 9.5%, and 4.1% among cancer patients; 91.9%, 86.4%, 78.1%, and 47.0% among dementia patients; and 91.9%, 86.4%, 78.1%, and 47.0% among patients with other nervous and cerebrovascular diseases, respectively. Cox proportional hazard regression clarified that cancer patients (hazard ratio 6.53 [95% CI 4.16–10.28]) and older adults (hazard ratio 1.01 [95% CI 1.00–1.02]) were significantly more likely to die than dementia patients and young patients, respectively. Primary disease had a significant influence on the prediction of survival time and could be a useful indicator to individualize ACP in home care setting. Lippincott Williams & Wilkins 2021-09-24 /pmc/articles/PMC10545356/ /pubmed/34559116 http://dx.doi.org/10.1097/MD.0000000000027225 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 6100
Kosaka, Makoto
Miyatake, Hirotomo
Kotera, Yasuhiro
Masunaga, Hidehisa
Arita, Satoshi
Tsunetoshi, Chie
Nishikawa, Yoshitaka
Ozaki, Akihiko
Beniya, Hiroyuki
The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study
title The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study
title_full The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study
title_fullStr The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study
title_full_unstemmed The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study
title_short The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study
title_sort survival time of end-of-life home care patients in fukui prefecture, japan: a retrospective observational study
topic 6100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545356/
https://www.ncbi.nlm.nih.gov/pubmed/34559116
http://dx.doi.org/10.1097/MD.0000000000027225
work_keys_str_mv AT kosakamakoto thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT miyatakehirotomo thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT koterayasuhiro thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT masunagahidehisa thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT aritasatoshi thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT tsunetoshichie thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT nishikawayoshitaka thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT ozakiakihiko thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT beniyahiroyuki thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT kosakamakoto survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT miyatakehirotomo survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT koterayasuhiro survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT masunagahidehisa survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT aritasatoshi survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT tsunetoshichie survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT nishikawayoshitaka survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT ozakiakihiko survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy
AT beniyahiroyuki survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy